Charles & Colvard stock reports USD 2.7 million asset sale after Chapter 11 filing

Charles & Colvard stock reported an OTC Markets quote of USD 0.000200 on September 18, 2026, while its 2026 performance stood at a loss of 99.86 percent. The latest company filing describes an asset sale, ceased operations and an ongoing Chapter 11 plan process.

Asset sale resets the case

As TradingView reported on September 3, 2026, Charles & Colvard filed a monthly operating report for the period ended July 31, 2026. The report said the debtor sold its assets, ceased operations and was working with counsel on a Chapter 11 plan.

The sale proceeds totaled USD 2.7 million on July 1, 2026, according to Stock Titan. That transaction changes the investment case from operating performance to bankruptcy recoveries and the treatment of common equity.

Cash balance shapes recovery

The July report listed USD 10,525 in receipts and USD 10,307 in disbursements for one operating account, leaving an ending reconciled balance of USD 24,143. The figures cover July 1 through July 31, 2026, rather than a normal operating quarter.

Stock Titan also reported USD 191,239 in accounts receivable against USD 594,993 in post-petition accounts payable for the period. The same filing warned that common shareholders may experience a significant or complete loss, depending on the Chapter 11 outcome.

OTC quote stays at USD 0.000200

The September 18, 2026 OTC Markets quote was USD 0.000200, with volume of 140,355 shares. The quoted stock performance was down 33.33 percent over five trading days and down 99.86 percent since January 1, 2026.

For investors, the key distinction is between the quoted market value and any eventual bankruptcy recovery. The July report’s USD 24,143 ending cash balance and the USD 2.7 million asset sale describe estate resources, not a payment to common shareholders.